Loading data for NNVC — first visit, this takes a few seconds.
NanoViricides, Inc. (NNVC)
NYSE American: NNVC
· 实时价格 · USD
1.21
-0.04 (-3.20%)
收盘价： Sep 04, 2026, 8:00 PM
1.11
-0.90%
盘后: 7:49 PM
股价、关键数字和最新消息，都在这一页。
NanoViricides, Inc.（NNVC）股价、分析与数据
暂无数据
| 买价 | 1.21 |
| 市值 | 28.6M |
| 营收（TTM） | n/a |
| 净利润（TTM） | -8.09M |
| 1.66 | |
| -0.44 | |
| n/a | |
| -3.2 | |
| 市净率（TTM） | 2.65 |
| 市销率（TTM） | 0.00 |
| 财报日期 | n/a |
| 卖价 | 1.22 |
| 成交量 | 189,844 |
| 20日均量 | 348,031 |
| 开盘价 | 1.24 |
| 前收盘价 | 1.25 |
| 日内区间 | 1.21 - 1.25 |
| 52周区间 | 0.85 - 2.23 |
| 分析师 | n/a |
| 目标价 | n/a |
| 分红 | n/a |
| 除息日 | n/a |
关于 NNVC
NanoViricides, Inc., a clinical stage nano-biopharmaceutical company, discovers, develops, and commercializes drugs to combat viral infections. The company's product portfolio includes NV-387 drug candidate developed for RSV and influenza indications and has completed phase 1a/1b human clinical trial for the evaluation of safety and tolerability; NV-387 as an active ingredient of drug product formulations for the treatment of COVID infections com...
公司完整简介财报意外
NanoViricides 已于 May 15, 2026 发布季度财报：
- 营收为 $0 低于预期 $0, ， NaN% 同比增长.
- 每股收益为 -0.09 低于预期 -0.01, ， 43.75% 同比增长.
第 1 页，共 2 页